Related references
Note: Only part of the references are listed.Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2008)
Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis -: relationship with bone mineral density, disease activity and bone turnover
P. Oelzner et al.
CLINICAL RHEUMATOLOGY (2007)
Epidemiology of osteoporosis in rheumatic diseases
Luigi Sinigaglia et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2006)
Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis
M Skoumal et al.
RHEUMATOLOGY INTERNATIONAL (2005)
RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes
G Page et al.
ARTHRITIS AND RHEUMATISM (2005)
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
MC Lodder et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis
Y Abu-Amer et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis
N Saidenberg-Kermanac'h et al.
BONE (2004)
Role for osteoprotegerin in rheumatoid inflammation
N Saidenberg-Kermanac'h et al.
JOINT BONE SPINE (2004)
Bone destruction in arthritis
EM Gravallese
ANNALS OF THE RHEUMATIC DISEASES (2002)
High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor α treatment
M Ziolkowska et al.
ARTHRITIS AND RHEUMATISM (2002)
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
E Romas et al.
BONE (2002)
Mechanism of hypercalcemia in adult T-cell leukemia:: overexpression of receptor activator of nuclear factor κB ligand on adult T-cell leukemia cells
K Nosaka et al.
BLOOD (2002)
The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China
ZH Liu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2002)
Minireview: The OPG/RANKL/RANK system
S Khosla
ENDOCRINOLOGY (2001)
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
DR Haynes et al.
RHEUMATOLOGY (2001)
Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption
PJ Kostenuik et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
The effect of a single dose of osteoprotegerin in postmenopausal women
PJ Bekker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Diagnostic criteria for primary osteoporosis: year 2000 revision
H Orimo et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2001)
Share Paper
